UCLA Department of Internal Medicine, UCLA Health/ David Geffen School of Medicine, UCLA Medical Education Office, RRUCLA Medical Center, 757 Westwood Plaza, Suite 7501, Los Angeles, CA 90095, USA. Electronic address: https://twitter.com/meganrmcleod.
Vatche and Tamar Manoukian Division of Digestive Diseases, Center for Health Sciences, 650 Charles E. Young Drive South, Suite A2-125, Los Angeles, CA 90095-6900, USA. Electronic address: https://twitter.com/DrGaloosianMD.
Hematol Oncol Clin North Am. 2022 Jun;36(3):415-428. doi: 10.1016/j.hoc.2022.02.003. Epub 2022 Apr 30.
Colorectal cancer (CRC) incidence and mortality vary by race and ethnicity in the United States, with the highest burden of disease among Black and American Indian/Alaska Native individuals. There are multiple contributors to these disparities, including lifestyle and environmental risk factors that result from adverse social determinants of health and are more prevalent in minority and medically underserved communities. In addition, participation in CRC screening, which is demonstrated to reduce CRC-related mortality, is lower in all racial/ethnic minority groups than for White individuals. Evidence-based efforts to reduce CRC disparities aim to increase screening uptake via multicomponent and culturally tailored interventions.
结直肠癌(CRC)的发病率和死亡率因美国的种族和民族而异,疾病负担最重的是黑人和美国印第安人/阿拉斯加原住民。造成这些差异的原因有很多,包括生活方式和环境风险因素,这些因素是由健康的不利社会决定因素造成的,在少数民族和医疗服务不足的社区更为普遍。此外,结直肠癌筛查的参与率,这被证明可以降低结直肠癌相关的死亡率,在所有种族/少数民族群体中都低于白人。旨在通过多组分和文化适应的干预措施来提高筛查参与率的循证努力,旨在减少结直肠癌的差异。